Our nomograms incorporating significant SNPs in the BMP/Smad4/Hamp hepcidin‐regulating pathway could improve the prediction of outcomes in patients given definitive radiotherapy for NSCLC. Here, HAMP is linked to non-small cell lung carcinoma.